Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: reply

Masaru Kato^*, Keita Ninagawa, Tatsuya Atsumi

^*この論文の責任著者

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
ページ（範囲）	E278-E279
ジャーナル	Rheumatology (United Kingdom)
巻	62
号	9
DOI	https://doi.org/10.1093/rheumatology/kead037
出版ステータス	出版済み - 2023/09/01

ASJC Scopus 主題領域

@article{71d5a77262e9477f8c11c9841f23b7e6,

title = "Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: reply",

author = "Masaru Kato and Keita Ninagawa and Tatsuya Atsumi",

year = "2023",

month = sep,

day = "1",

doi = "10.1093/rheumatology/kead037",

language = "英語",

volume = "62",

pages = "E278--E279",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Comment on

T2 - Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: reply

AU - Kato, Masaru

AU - Ninagawa, Keita

AU - Atsumi, Tatsuya

PY - 2023/9/1

Y1 - 2023/9/1

UR - http://www.scopus.com/inward/record.url?scp=85169502538&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kead037

DO - 10.1093/rheumatology/kead037

M3 - Letter

C2 - 36707999

AN - SCOPUS:85169502538

SN - 1462-0324

VL - 62

SP - E278-E279

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 9

ER -